1. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis
   Yong-Zheng Zhang et al, 2022, Front. Immunol. CrossRef
2. Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma
   Xiaokai Zhang et al, 2023, Translational Oncology CrossRef
3. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy
   Pooya Farhangnia et al, 2023, Front. Immunol. CrossRef
4. Macrophage N-glycan processing inhibits antibody-dependent cellular phagocytosis
   Jesús S Aguilar Díaz de león et al, 2023 CrossRef
5. A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
   Jianping Sun et al, 2023, Sci Rep CrossRef
6. Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma
   Zongqiang Hu et al, 2024, International Immunopharmacology CrossRef
7. The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
   Xinyi Zhang et al, 2023, Cancer Medicine CrossRef
8. Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors
   Metin Gunes et al, 2024, Front. Immunol. CrossRef
9. null
   Laura Amo et al, 2024 CrossRef